SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001399529-19-000013
Filing Date
2019-05-09
Accepted
2019-05-09 16:24:26
Documents
3
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drna-20190510x8k.htm 8-K 30324
2 EXHIBIT 99.1 drna-20190510xex991.htm EX-99.1 100516
3 dicernareports1q19fin_image1.jpg GRAPHIC 22788
  Complete submission text file 0001399529-19-000013.txt   163488
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 19810926
SIC: 2834 Pharmaceutical Preparations